IPP Bureau
Granules India CFO Sandip Neogi resigns
By IPP Bureau - November 29, 2022
The company is in the process of appointing a new CFO.
Fredun Pharmaceuticals signs two large contracts
By IPP Bureau - November 29, 2022
Fredun received one-year contract worth Rs. 65 crores from a Southeast Asian country for Pharma exports
CPhI and P-MEC India sees participation of over 1500 exhibitors
By IPP Bureau - November 29, 2022
40,000 visitors and representatives of more than 80 countries set to visit the show
Azelis inaugurates pharmaceuticals & healthcare lab for APAC in India
By IPP Bureau - November 28, 2022
The pharma laboratory is fully equipped with all the machinery needed to support formulation development, resolve technical challenges, and provide customer demonstrations
Sai Life Sciences appoints Stephen Hermitage as VP, CMC
By IPP Bureau - November 28, 2022
Steve joins Sai Life Sciences from GlaxoSmithKline (GSK) where he was a department head and member of the global chemical development leadership team.
Philips advances AI-powered diagnostic systems and transformative workflow solutions
By IPP Bureau - November 28, 2022
Latest innovations feature vendor-neutral solutions to help reduce clinical complexity and enhance operational efficiency
Japan approves ENHERTU for treatment of adult patients with HER2 positive unresectable breast cancer
By IPP Bureau - November 27, 2022
Approval broadens indication for ENHERTU to earlier use in metastatic breast cancer and requirement for confirmatory phase 3 trial
Chantal van Gils joins NDA Advisory Board as Director of Epidemiology
By IPP Bureau - November 27, 2022
She will provide strategic advice and scientific leadership to support clients in clinical development, registration strategy, submission, early post-approval strategy
Early detection of lung cancer vital to combat rising mortality rate, says GlobalData
By IPP Bureau - November 27, 2022
The only definitive way to diagnose and stage lung cancers is through biopsies
LPU organizes conference on welfare of global community
By IPP Bureau - November 27, 2022
Joint Drugs Controller (India) Dr PBN Prasad shared his views about working during harsh COVID-19 pandemic days
Panchsheel Organics to set up fermentation/API unit
By IPP Bureau - November 27, 2022
Total investment envisaged in this project stands at up to Rs 70 crore
Briefs: IOL Chemicals and Cipla
By IPP Bureau - November 27, 2022
Government of India has granted a patent for invention entitled "An improved safe process for the preparation of Sartan drugs of Formula I".
Delivery solution provider ZIM Laboratories Limited lists on NSE
By IPP Bureau - November 26, 2022
The total quantity traded at NSE stood at 34,653 shares and the total turnover stood at Rs. 117.23 lakh.
AstraZeneca receives import and market permission from CDSCO for Dapagliflozin
By IPP Bureau - November 26, 2022
The receipt of this permission paves way for the launch of Dapagliflozin (Forxiga) tablets of 10 mg in India for the specified additional/expanded indication, subject to the receipt of related statutory approvals
Ministry of Ayush and DST sign MoU to identify areas of research
By IPP Bureau - November 26, 2022
The two have agreed to jointly undertake R&D activities on scientific validation of Ayush concepts, procedures and products
